A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)
Clinical trial NCT03547167 · COMPLETED
Trial details
- NCT number
- NCT03547167
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-16
- Primary completion
- 2020-01-20
- Enrollment
- 1515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.